Futura Medical: Change of Advisers

Futura Medical PLC 28 February 2005 RNS Release 28 February 2005 Futura Medical change in Nominated Adviser and Broker Futura Medical plc ('Futura'), the AIM-quoted pharmaceutical drug and medical device group that develops innovative products for the sexual healthcare market, announces the following adviser appointments with immediate effect: Nominated Adviser Canaccord Capital (Europe) Limited Joint brokers Collins Stewart Limited Canaccord Capital (Europe) Limited remains joint broker. For further information: Futura Medical plc James Barder, Chief Executive Tel: +44 (0) 1483 845 670 Canaccord Capital (Europe) Ltd Stephen Rowntree Tel: +44 (0)20 7518 7371 Collins Stewart Ltd Chris Howard Tel: + 44 (0) 20 7523 8350 Media enquiries: Abchurch Peter Curtain / Alex Tweed Tel: +44 (0) 20 7398 7700 mailto: alex.tweed@abchurch-group.com www.abchurch-group.com www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock Exchange DGGUI